ALKS PEER ANALYSIS

Alkermes Plc — metric-by-metric comparison with peers and the industry median

ALKSAlkermes Plc

🇺🇸 USA · NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

Value it Duel

Overall Profile & Returns

· Drug Manufacturers - Specialty & Generic

Position Within Industry

0 = weak quartile, 100 = strong quartile

ALKSIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	ALKS	ROVI	BHC	MRK	ECILC	GENIL	Ind. Median
P/E	59.40	22.08●	—	25.00	—	46.82	21.37
P/B	5.18	4.32	-0.88●	2.13	0.80	3.47	1.82
EV/EBITDA	36.69	14.64	4.05●	11.99	33.84	14.07	12.26
P/S	5.81	3.93	0.21●	3.02	5.03	1.86	2.09

Financial Health
Metric	ALKS	ROVI	BHC	MRK	ECILC	GENIL	Ind. Median
Current Ratio	2.27	3.66●	1.32	1.51	1.73	1.33	2.22
Debt/Equity	90.3%	17.0%	-1,010.0%●	40.5%	5.9%	41.0%	46.3%
NetDebt/EBITDA	3.87	0.09	3.71	1.38	-0.10●	1.10	1.24

Profitability
Metric	ALKS	ROVI	BHC	MRK	ECILC	GENIL	Ind. Median
Net Margin	9.8%	17.8%●	-13.5%	12.1%	-3.6%	4.0%	4.0%
ROE	9.4%	20.9%●	—	8.5%	-0.6%	8.7%	6.4%
ROA	4.8%	15.1%●	-4.7%	4.9%	-0.5%	4.8%	3.4%
EBITDA Margin	17.7%	27.0%	60.0%●	28.5%	14.8%	14.3%	18.2%

Growth + Dividend
Metric	ALKS	ROVI	BHC	MRK	ECILC	GENIL	Ind. Median
Rev. Growth	3.2%	-3.4%	-9.9%	-1.7%	-2.3%	16.3%●	7.5%
NI Growth	-56.7%	-5.9%	—	-10.1%	—	146.6%●	5.0%
Div. Yield	—	1.6%	0.0%	1.5%	2.6%●	0.0%	2.0%
Payout	—	36.3%	0.0%	11.8%	-365.1%	0.0%	0.8%

Valuation
Metric	ALKS	HIMS	LQDA	LNTH	ELAN	AMRX	Ind. Median
P/E	59.40	—	357.80	25.90●	—	46.10	21.37
P/B	5.18	18.83	73.50	5.96	1.95	-124.23●	1.82
EV/EBITDA	36.69	292.27	147.65	15.56	21.22	13.00●	12.26
P/S	5.81	3.55	27.70	4.67	2.59	1.85●	2.09

Financial Health
Metric	ALKS	HIMS	LQDA	LNTH	ELAN	AMRX	Ind. Median
Current Ratio	2.27	1.69	2.22	2.83●	2.16	2.47	2.22
Debt/Equity	90.3%	253.7%	170.2%	51.6%	61.4%	-5,938.0%●	46.3%
NetDebt/EBITDA	3.87	12.68	-0.71●	0.27	4.66	3.99	1.24

Profitability
Metric	ALKS	HIMS	LQDA	LNTH	ELAN	AMRX	Ind. Median
Net Margin	9.8%	-0.6%	7.7%	18.0%●	-4.9%	4.0%	4.0%
ROE	9.4%	-2.7%	28.2%●	23.5%	-3.8%	—	6.4%
ROA	4.8%	-0.8%	7.1%	12.7%●	-1.8%	3.5%	3.4%
EBITDA Margin	17.7%	1.3%	18.7%	30.6%●	15.6%	20.6%	18.2%

Growth + Dividend
Metric	ALKS	HIMS	LQDA	LNTH	ELAN	AMRX	Ind. Median
Rev. Growth	3.2%	32.8%	1,936.7%●	0.6%	10.5%	7.6%	7.5%
NI Growth	-56.7%	—	—	9.7%●	—	—	5.0%
Div. Yield	—	—	—	—	—	—	2.0%
Payout	—	—	—	—	—	—	0.8%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on ALKS

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.